Amneal Pharmaceuticals, Inc.
AMRX
$11.82
-$0.37-3.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.28% | 4.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.28% | 4.18% | |||
| Cost of Revenue | 11.34% | -0.23% | |||
| Gross Profit | 3.55% | 11.85% | |||
| SG&A Expenses | 10.90% | 5.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.86% | 3.03% | |||
| Operating Income | -16.73% | 10.99% | |||
| Income Before Tax | -110.10% | 37.95% | |||
| Income Tax Expenses | -245.05% | 25.12% | |||
| Earnings from Continuing Operations | -49.08% | 44.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -19.48% | -6.20% | |||
| Net Income | -89.43% | 83.82% | |||
| EBIT | -16.73% | 10.99% | |||
| EBITDA | -14.39% | 6.86% | |||
| EPS Basic | -89.51% | 82.40% | |||
| Normalized Basic EPS | -23.79% | 70.41% | |||
| EPS Diluted | -89.29% | 78.57% | |||
| Normalized Diluted EPS | -24.26% | 72.65% | |||
| Average Basic Shares Outstanding | 0.14% | 0.86% | |||
| Average Diluted Shares Outstanding | 0.74% | -0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||